Aquestive Therapeutics, Inc.AQSTNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, strong compound growth.
Left:
|
|
|
|

Profit from core business operations before interest and taxes

Latest
$-30.77M
Near historical average
Average (8y)
$-29.79M
Historical baseline
Range
High:$-113000.00
Low:$-52.67M
CAGR
+56.7%
Consistent expansion
PeriodValueChange
2024$-30.77M-103.8%
2023$-15.10M+64.1%
2022$-42.07M-21.3%
2021$-34.68M+19.1%
2020$-42.89M+18.6%
2019$-52.67M-7.6%
2018$-48.93M-43204.4%
2017$-113000.00+86.7%
2016$-847000.00-